FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
By Jen Christensen, CNN The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease.
The Remarkable Benefits of Intrathecal Medicine
Intrathecal medicine, a form of therapy involving the administration of medications directly into the spinal canal, has emerged as a groundbreaking approach in the field of healthcare. This targeted delivery method offers a range of benefits and has revolutionized the treatment of various medical conditions, providing relief and hope to countless individuals worldwide.
Napa Pain Institute Awarded Prestigious Best of Napa Medical Facility 2023
The “Best of Napa Medical Facility” award, presented annually by The Best of Napa and The Press Democrat, celebrates and honors healthcare facilities that demonstrate exceptional dedication, innovation, and superior service in their respective fields. Napa Pain Institute has emerged as a distinguished institution, setting new benchmarks for combining patient care and medical innovation in the private practice setting.
How Do I Treat Chronic Back Pain?
Chronic low and back pain can be debilitating, affecting every aspect of a person’s life. Fortunately, there are several effective treatments available, including interventional therapies. These treatments involve the use of minimally invasive procedures to target the source of the pain and provide relief.
What is Cancer Pain?
Cancer pain is a complex and often debilitating symptom that can result from the disease itself or its treatments. Pain management is an essential component of cancer care, and there are several treatment options available to help manage cancer pain.
What is Pain?
Chronic pain is a debilitating condition that affects millions of people worldwide. According to the Centers for Disease Control and Prevention (CDC), approximately 20% of adults in the United States suffer from chronic pain, and this number is increasing. Chronic pain can have a significant impact on a person’s quality of life, leading to depression, anxiety, and social isolation.
Dr. Melanie Johansson Joins the Napa Pain Institute
Dr. Melanie Johansson joins the Napa Pain Institute as a fellowship-trained and board-certified pain management specialist with well over a decade of medical experience. Dr. Johansson treats patients for chronic back pain, headache and neuropathic pain, osteoporosis, chronic pain from injuries and more.
Neurovations Receives 2022 Best of Napa Award for Outstanding COVID Testing Services
NapaCovid has been selected for the 2022 Best of Napa Award in the Medical Clinic category.
Spinal cord stimulation advances therapy for painful diabetic peripheral neuropathy
Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition.
Neurovations Awarded 6.9 million-Dollar Grant for Groundbreaking Educational Pain Research Program
Dr. Eric Grigsby, Founder and CEO of Neurovations, announced that Neurovations Education is the recipient of a 6.9 million-dollar grant from the Helping to End Addiction Long-term Initiative®, or NIH HEAL Initiative®.